NYC BUILDS BIO INC (EIN 832265630) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

NANCY KELLEY

Phone

2124507300

Tax Period

2023-01-01 to 2023-12-31

NYC BUILDS BIO INC, founded in 2018, is a small nonprofit in the Science & Technology sector that reported $570K in total revenue in fiscal year 2023. Revenue grew 13% year-over-year, indicating healthy expansion.

Mission

BUILDS BIO+ IS A MEMBERSHIP-DRIVEN ORGANIZATION DEDICATED TO CONNECTING LIFE SCIENCE AND REAL ESTATE PROFESSIONALS THROUGH CURATED EVENTS, COMPREHENSIVE RESEARCH, INDUSTRY REPORTS AND EDUCATIONAL PROGRAMS. BUILDS BIO+ ENHANCES VISIBILITY AND FOSTERS INNOVATION AND ECONOMIC GROWTH WITHIN MAJOR REGIONAL LIFE SCIENCE CLUSTERS AND SERVES AS A HUB FOR THE LIFE SCIENCES INNOVATION COMMUNITY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $569,647

Investment Income $0

Other Revenue $0

TOTAL REVENUE $569,647

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $445,529

Other Expenses $580,683

TOTAL EXPENSES $580,683

Year-over-Year Comparison

	2023	2022	Change
Revenue	$569,647	$501,953	+0.1%
Expenses	$580,683	$468,645	+0.2%
Net Income	$-11,036	$33,308	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
NANCY J KELLEY	CO-PRESIDENT	9.00	Officer Director	$0	$0	$0
MITCHEL W SIMPLER	CO-PRESIDENT	9.00	Officer Director	$0	$0	$0
PETER SCHUBERT ELECTED 1223	DIRECTOR	1.00	Director	$0	$0	$0
JONATHAN MECHANIC	DIRECTOR	1.00	Director	$0	$0	$0
BRIAN ARONNE ELECTED 1223	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$569,647	$580,683	$27,802	$-11,036
2022	$501,953	$468,645	$38,839	$33,308
2021	$352,473	$359,272	$5,531	$-6,799
2020	$261,192	$254,473	$12,330	$6,719
2019	$337,727	$365,680	$5,611	$-27,953

NYC BUILDS BIO INC